Dentsply Sirona, Inc. (XRAY) launched a comprehensive restage of its Implants business to introduce a different way of performing implantology and provide better solutions from scan to crown.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Shares of the manufacturer of dental products and technologies worldwide have gained 39% over the past year. (See Dentsply Sirona stock charts on TipRanks)
The new offering comprises three completely connected, seamless signature workflows that will utilize digital dentistry to enhance efficiency, accuracy, aesthetics, longevity, and simplicity.
Further, the company unveiled DS PrimeTaper, the next step in implant dentistry, offering higher accuracy, repeatability of processes, time savings, and long-term bone stability. It is a self-tapping implant with a tapered design that can be inserted safely and easily with the help of a unique double thread.
Dr. Terri Dolan, Chief Clinical Officer at Dentsply Sirona, commented, “Our goal is to enable clinicians, including both specialists and general practitioners, to focus on what they do best – creating healthy and beautiful smiles. Our vision for digital implant dentistry will be supported by a global clinical education program focused on end-to-end digital implant workflow solutions to achieve clinic, technical and practice excellence.
He further added, “The extensive curriculum is designed to build clinicians’ digital implant skills according to their level of experience and personal learning preferences. These include online education and personalized learning, as well as more than 50 state-of-the art Dentsply Sirona Academy education centers around the world.”
Evercore ISI analyst Elizabeth Anderson recently reiterated a Buy rating on the stock with a price target of $74 (23.3% upside potential).
Anderson forecasts the company to report earnings of $0.45 per share in the third quarter of 2021.
Consensus among analysts is a Moderate Buy based on 5 Buys and 2 Holds. The average Dentsply Sirona price target of $386.19 implies 13.13% upside potential to current levels.
XRAY scores a “Perfect 10” on TipRanks’ Smart Score rating system, indicating that the stock has strong potential to outperform market expectations.
Related News:
Accenture Posts Strong Q4 Results and Fiscal 2022 Guidance; Shares Pop 2.5%
Progress Software Shares Leap 9% on Q3 Beat and Raised Guidance
McDonald’s Hikes Dividend by 7%, Restarts Buybacks
